Clinical Trial Update: A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis [Phase 2]

View source ↗

Summary

Pfizer is conducting a Phase 2 pediatric trial to evaluate how etrasimod works in children with ulcerative colitis; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Etrasimod (etrasimod)

Snippet

Sponsor: Pfizer | Conditions: Colitis, Ulcerative | Phase 2 | Status: NOT_YET_RECRUITING